• Home
  • GROUP HOME
  • About
    • Group CEO
    • Management Team
    • Supervisory Board
    • Scientific Advisory Board
    • Affiliates
    • R&D Partnerships
    • Distributors
    • Quality Standards
    • Location
  • R&D
  • Products
    • MEMORYLINC
    • NEUROLINCS
    • FIMICS
    • ELISA Kits
    • Recombinant Proteins
    • Monoclonal Abodies
    • Clinical Samples
  • Quality
  • Investors
    • Financial Management
    • Financial Data
    • Shareholders
  • Media
    • Press Releases
    • Media News
    • Newsletters
    • Posts
    • All Media
  • Careers
Firalis
  • About
    • Group CEO
    • Management Team
    • Supervisory Board
    • Scientific Advisory Board
    • Affiliates
    • R&D Partnerships
    • Distributors
    • Quality Standards
    • Location
  • Products
    • MEMORYLINC
    • NEUROLINCS
    • FIMICS
    • ELISA Kits
    • Recombinant Proteins
    • Monoclonal Abodies
    • Clinical Samples
  • R&D
  • Quality
  • Media
    • Press Releases
    • Media News
    • Newsletters
    • Posts
    • All Media
contact

MMP9  Stability

 

 

Name of the kit Kit reference

Kit 

Stability date (dd-mm-yyyy)

MMP9

FLS-BP-09 FLS-BP09-01 01-09-2024

 

gdrgdrryrey

ghdfhthtrhr

bfdbgfhgfh


Graduated from the Strasbourg Management School, Alain has had a true entrepreneur life cycle, held various management titles such as Executive Vice President, President and Chief Executive Officer. Alain founded the Alsatian capital-development company Cardinale Développement of which he is still a Partner. Among many Executive Boards in which he is a member, Alain holds the Chairman seat on Delta Inter Management as well as on the Supervisory Board of Firalis S.A.

For more information on Alain GOETZMANN

     
     
     
     
     
     

 

Follow us on LinkedIn